Related Experiment Video
Updated: Jul 31, 2025

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
Standardisation and future of preclinical echocardiography
Caroline E O'Riordan1, Philippe Trochet2, Magdelena Steiner2
1FUJIFILM VisualSonics, Inc, Amsterdam, The Netherlands. caroline.oriordan@fujifilm.com.
This review examines the current state and future of using ultrasound to study heart health in small animals. It highlights the need for consistent reporting standards to improve research quality and reliability across different animal models and life stages.
Area of Science:
- Preclinical echocardiography research within cardiovascular medicine
- Diagnostic imaging technology in veterinary science
Background:
No prior work has fully resolved the inconsistencies in reporting preclinical cardiac ultrasound data. That uncertainty drove researchers to evaluate existing protocols across diverse animal models. It was already known that high-frequency transducers allow for detailed visualization of rodent hearts. However, the lack of uniform measurement standards limits the comparability of findings between different laboratories. This gap motivated a comprehensive assessment of current imaging practices. Prior research has shown that real-time monitoring of cardiac function is possible from embryonic stages through adulthood. Yet, the field lacks a consensus on which parameters are most critical for reporting. This review addresses the urgent requirement for standardized methodologies in small animal imaging.
Purpose Of The Study:
The aim of this review is to evaluate the development of standardisation in preclinical echocardiography. The authors address the specific problem of inconsistent reporting practices in small animal cardiac research. This motivation stems from the need to improve the reliability and comparability of data across different laboratories. The study explores how advancements in high-frequency transducer technology have enabled detailed heart imaging in rodents. It investigates the appropriate cardiac measurements that should be reported for various developmental stages. The researchers examine the challenges associated with monitoring both acute and chronic heart conditions in small models. By synthesizing current knowledge, the study seeks to establish a framework for more consistent imaging protocols. This work ultimately provides a foundation for future improvements in preclinical cardiovascular assessment methodologies.
Main Methods:
The review approach involved a systematic evaluation of current literature regarding small animal cardiac imaging. Investigators synthesized data from studies utilizing various rodent models, including embryonic and neonatal subjects. The authors examined existing protocols to identify common discrepancies in reported cardiac parameters. This review approach prioritized studies that employed high-frequency transducer technology for enhanced spatial resolution. Researchers assessed the utility of alternative models like zebrafish and chicken embryos within the broader context of cardiovascular investigation. The analysis focused on identifying optimal measurement techniques for both healthy and diseased states. Reviewers categorized findings based on the developmental stage and the specific pathological condition being monitored. This approach ensured a comprehensive overview of current practices and identified areas requiring improved standardization.
Main Results:
Key findings from the literature indicate that ultra-high-frequency transducers provide spatial resolution down to 30 micrometers in small animal models. The review demonstrates that real-time monitoring of cardiac function is feasible across the entire lifespan of rodents. Findings show that current research frequently utilizes mice and rats, with increasing adoption of zebrafish and chicken embryos. The literature confirms that standardized reporting is currently lacking for many preclinical cardiac measurements. Results highlight that inconsistent data collection hampers the ability to compare findings across different laboratories. The synthesis reveals that cardiac function can be effectively tracked in acute and chronic pathological models. Evidence suggests that the field is shifting toward more sophisticated imaging techniques to improve diagnostic accuracy. The authors report that establishing clear guidelines for measurement is the most significant requirement for future progress.
Conclusions:
The authors propose that establishing uniform reporting guidelines will enhance the reproducibility of preclinical cardiovascular studies. Synthesis and implications suggest that adopting standardized cardiac measurements is necessary for cross-study comparisons. Researchers indicate that future advancements will likely integrate automated analysis to reduce operator-dependent variability. The review emphasizes that consistent data collection across the lifespan of rodents remains a priority. Authors suggest that expanding these standards to alternative models like zebrafish will improve translational accuracy. The synthesis highlights that standardized protocols are vital for assessing both acute and chronic heart conditions. Implications for the field include a shift toward more rigorous and transparent imaging documentation. The authors conclude that ongoing refinement of these metrics will support more reliable preclinical research outcomes.
Frequently Asked Questions
The researchers propose that standardizing reporting metrics across rodent lifespans improves data reliability. While standard echocardiography provides real-time structural insights, the authors argue that consistent measurement protocols are necessary to mitigate variability between different laboratories and experimental models.
The authors identify ultra-high-frequency transducers as the key technology enabling high-resolution imaging. These tools allow for spatial resolutions down to 30 micrometers, which is necessary for visualizing small structures in mice and rats compared to traditional clinical ultrasound equipment.
The authors state that standardized measurements are necessary because current practices lack uniformity. Without these protocols, comparing cardiac function across different developmental stages, such as embryonic versus adult models, remains difficult for researchers seeking to validate therapeutic interventions.
The authors explain that in vivo real-time imaging serves as the primary data type for monitoring cardiac function. This approach allows investigators to track structural changes throughout the lifespan of rodents, providing a dynamic view of heart health that static imaging cannot capture.
The authors measure cardiac function across various life stages, including embryonic, neonatal, and aging rodents. They contrast these developmental phases with acute and chronic pathological conditions to demonstrate the versatility of current ultrasound techniques in diverse experimental settings.
The researchers propose that the future of the field involves integrating automated analysis to enhance precision. They suggest that this transition will reduce human error and facilitate more robust data collection compared to current manual assessment methods.
More Related Videos
09:31Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Related Concept Videos
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...